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The applicability of the results of any clinical trial will depend to a large extent on whether the study 
population is representative of the population seen in clinical practice. The growing older surgical 
population presents challenges for peri-operative researchers to ensure there is adequate 
representation of patients in terms of their age, sex, race and ethnicity in clinical trials. A review of 
purposively sampled published randomised controlled trials was performed to establish the age, sex, 
race and ethnicity of study participants. These data were compared to national registry data for the 
relevant surgical populations. We included 224 peri-operative trials that had been cited in 469 
retrieved meta-analyses. Of these, 50 (22.3%) had an upper age limit to recruitment. The median 
(range [IQR]) difference in study population age from the registry population age was -2.4 (-6.2 to 
1.0 [-34.7 to 14.5]) years for all the randomised controlled trials identified, -6.2 (-9.4 to -2.8 [-18.6 to 
4.6]) years for randomised controlled trials investigating patients undergoing hip arthroplasty and -
3.4 (-9.6 to -1.1 [-34.7 to 2.9]) years for trials involving patients undergoing surgery for fractured 
neck of femur. In 92 (41.1%) randomised controlled trials, the proportion of each sex in the study 
population was more than 25% different from the proportion in the registry population. Only 5 
(2.2%) published data on the race or ethnicity of participants. We conclude that peri-operative 
randomised controlled trials are unlikely to be representative of the age and sex of clinically treated 
surgical populations. Researchers must endeavour to ensure representative study populations are 





































The applicability of the results of any clinical trial depends to a large extent on whether the study 
population is representative of the population of patients treated in clinical practice. Ideally, this 
would at least include representation of: age; sex; race; and ethnicity. The global population is 
ageing, and it is predicted that by 2050, the number of people aged > 60 y will more than double to 
2.1 billion [1]. Fowler et al. have shown that the population of patients having surgery in England are 
ageing faster than the population as a whole, and estimate that by 2030, one-fifth of those aged > 75 
y will undergo surgery each year [2].    
 
Under-representation of older patients in clinical trials [3–5] has resulted in numerous agencies 
producing guidance on the inclusion of older patients to improve adequate representation and 
hence the applicability of any findings [6,7]. Historically, there has been an under-recruitment of 
females to clinical trials [8]. This has been in part attributed to the discouragement of females of 
child-bearing age from participation, particularly following the thalidomide scandal of the 1960s [9]. 
Reporting on this issue together with publication of guidance on clinical trial sex-representation 
appears to have resulted in improved representation [9,10]. Despite this, female under-
representation in clinical research continues to be reported [11,12].  
 
The expanding and increasingly older surgical population presents challenges for peri-operative 
trialists to ensure there is adequate patient representation in clinical trials. We aimed to assess the 
adequacy of representation of: age; sex; race; and ethnicity of peri-operative research trials 
compared with contemporaneous national surgical populations. 
 
Methods 
We conducted a review of randomised controlled trials (RCTs) in peri-operative medicine. A 
purposive sampling approach was used, and we aimed to extract data on clinical trials likely to have 
been of greatest impact. Studies were selected that: aimed to answer a clinical question relevant to 
a high-volume major surgical population; examined core peri-operative domains; and were included 
in recent meta-analyses. 
 
We used English surgical registry data to identify major surgical procedures frequently performed on 
older people [13]. Seven different surgical subgroups were chosen: colorectal resection; elective hip 
arthroplasty; elective knee arthroplasty; operative management of fractured neck of femur; 
transurethral resection of prostate and transurethral resection of bladder tumour; nephrectomy; 
and lung resection. Selection criteria for surgical subgroups can be found in Supplementary Appendix 
S1. In England, these seven operative categories account for 125,000 operations per year in patients 
aged > 75 y and 228,000 operations in all patients (see Supplementary Appendix S2 for frequency of 
each operation stratified by age). The most common procedure in older adults is cataract surgery 
(221,000 procedures per year in patients aged > 75 y). Trials in these patients were excluded, as it is 
a minor procedure and peri-operative research in this area is sparse.  
 
Based on investigator discussions and following an initial scoping review of the literature, five 
domains of peri-operative interventions were chosen. These were: enhanced recovery after surgery; 
goal directed therapy; patient blood management; pain management; and pre-operative 
optimisation. Selection criteria for peri-operative domains can be found in Supplementary Appendix 
S1. We employed a purposive sampling strategy to identify peri-operative RCTs that have been 
included in meta-analyses, and are therefore likely to impact clinical practice. An initial search was 
performed to identify meta-analyses of the different peri-operative interventions in the specified 
surgical subgroups. Randomised controlled trials were then selected from these meta-analyses to be 
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used in our analysis. Literature searches were conducted using the electronic databases Ovid 
MEDLINE, Embase and the Cochrane Central Register of Controlled Trials.  
 
We performed 35 searches across seven surgical categories and five research domains. Results were 
restricted to systematic reviews published during 2009 or later. A full list of the search terms used 
can be found in Supplementary Appendix S3. The search was conducted on 28 December 2018. The 
titles and abstracts of the search results were screened independently by two investigators. Any 
disagreement was resolved by a third investigator. Meta-analyses investigating the specified peri-
operative intervention in the specified surgical subgroup were selected. Studies looking specifically 
at paediatric populations were excluded.  
 
Full texts of meta-analyses identified by our literature search were reviewed to ensure they met the 
inclusion criteria. Randomised controlled trials cited in the retrieved meta-analyses were selected. If 
there were 20 or more RCTs identified for any of the 35 search categories, the 10 most recent and 
then the 10 most cited of the remaining RCTs were used in our analysis. The full text of each of the 
identified RCTs was reviewed independently by two investigators. Any disagreement was resolved by 
a third investigator. The following data were extracted: the year of start and end of study 
recruitment; the country of treatment of the primary study population; the number of participants; 
the proportion of females; central values (mean or median) and spread (standard deviation or 
interquartile range); whether an age subgroup analysis was performed; whether participant race or 
ethnicity was reported (as defined by the primary study authors); the presence of any study 
population inclusion or exclusion criteria which the reviewer felt would exclude or bias against older 
people or a particular sex. The midpoints of the trial recruitment were used to represent the study 
year when making comparisons with registry data. 
 
We extracted information regarding surgical subgroup population age and sex from the published 
data of three national registries: Hospital Episodes Statistics (England) [13], Federal Statistics Office 
of Germany [14] and Australian Institute of Health and Welfare [15]. Age data from the National Hip 
Fracture Database [16] were used in the analysis of RCTs involving patients undergoing surgical 
management of a fractured neck of femur. The procedure codes used to identify each of the surgical 
subpopulations in each of the registries are included in Supplementary Appendix S4. Where not 
available, total mean age and standard deviations were calculated from the age group data provided 
by the registries. Where registry data was reported for financial years, the start year was used in the 
analysis. Where registry data was not available for certain years, data from the nearest year with 
data recorded was used in the analysis. 
 
To report age representation, the mean registry age for the nearest year with available data was 
subtracted from the central value of the study age (mean or median). Values less than zero 
represent studies with average ages less than the corresponding registry population.  
Due to the asymmetrical sex balance in some populations (notably hip fracture), the sex 
representation was reported as the ratio of the proportion of male participants in the study 
compared to the proportion in the registry population. Values less than one represent under-
representation of males, and greater than one, over-representation. Due to the lack of reported data 
on race and ethnicity, these data are reported narratively.   
 
Data analysis was performed with Stata version 15 (Stata Corp, College Station, TX, USA).  
Data are presented descriptively. There is no inferential statistical analysis as this was felt to be 





We identified 469 meta-analyses from which we screened 1158 RCTs and included 366 (31.6%). Of 
these, 224 (61.2%) met the eligibility criteria and were included in the final analysis (Fig. 1). A 
definitive list of included studies is provided in Supplementary Appendix S5. Of the 224 RCTs: 63 
(28.1%) studied patients undergoing colorectal resection; 46 (20.5%) studied patients undergoing 
elective knee arthroplasty; 39 (17.4%) studied patients undergoing elective hip arthroplasty; 41 
(18.3%) studied patients undergoing surgical management of a fractured neck of femur; 4 (1.8%) 
investigated patients undergoing transurethral resection of prostate or transurethral resection of 
bladder tumour; 1 (0.4%) studied patients undergoing nephrectomy; and 34 (15.2%) investigated 
patients undergoing lung resection. Given the limited number of RCTs identified studying 
nephrectomy, transurethral resection of prostate and transurethral resection of bladder tumour 
populations, we did not perform individual analyses of these data. 
 
There was a total of 22,404 participants in all included RCTs. The median (IQR [range]) number of 
participants was 66 (45–110 [15–2016]). Of the 224 analysed RCTs, 114 (50.9%) were conducted in 
Europe, 34 (15.2%) in North America, 11 (4.9%) in Australasia, 64 (28.6%) in Asia, and 1 (0.4%) in 
South America. Registry data were qualitatively similar between all the included national registries. 
Data are therefore presented using the Hospital Episodes Statistics (England) database unless 
otherwise specified. For data on the age of patients undergoing operative management of fractured 
neck of femur, we used the National Hip Fracture Database. Additional analyses using German and 
Australian data are included in Supplementary Appendix S6. 
 
The median (IQR [range]) difference between the study population age (mean or median) and the 
registry population age (mean) was: -2.4 (-6.2 to 1.0 [-34.7 to 14.5]) years for all RCTs identified; 0.3 
(-4.3 to 3.0 [-28.2 to 9.8]) years for colorectal resection RCTs; -6.2 (-9.4 to -2.8 [-18.6 to 4.6]) years 
for elective hip arthroplasty RCTs; -1.7 (-3.2 to 0.3 [-8.8 to 6.2]) years for elective knee arthroplasty 
RCTs; -3.4 (-9.5 to -1.1 [-34.7 to 2.9]) years for surgery for fractured neck of femur RCTs; and -0.6 (-
6.6 to 3 [-23.5 to 14.5]) years for lung resection RCTs (Fig. 2).  
 
We made a judgement that 77 (34.4%) RCTs had exclusion criteria which might have unnecessarily 
excluded or biased against the inclusion of older people. Of these, 50 (22.3%) RCTs had an upper age 
limit to recruitment and 18 (7.4%) excluded patients with specified comorbidities, even though these 
participants were appropriate candidates for the study intervention. Eleven (4.5%) RCTs excluded 
patients based on ASA grade, despite this not being a clinical contra-indication to the study 
intervention. Thirteen (5.3%) RCTs excluded patients with cognitive impairment rather than on a 
formal assessment of capacity. 
 
Regarding the 41 RCTs on patients undergoing surgery for fractured neck of femur: 7 (17.1%) had 
exclusion criteria felt to unnecessarily exclude older patients; 5 (12.2%) had upper age limits to 
recruitment; 15 (36.6%) had a lower age limit to recruitment; and two (4.9%) published an age 
subgroup analysis.  
 
In 92 (41.1%) RCTs, the proportion of each sex in the study population was more than 25% different 
from the proportion in registry population. In 32 (14.3%) RCTs, the proportion of each sex in the 
study population was more than 50% different from the proportion in registry population (Fig. 3).  
 
Five (2.2%) RCTs published data on the race or ethnicity of participants.  
 
Discussion 
We found that our sample of peri-operative RCTs were insufficiently representative of the age of 
surgical populations treated in clinical practice. While there was often misrepresentation of sex in 
individual RCTs, we did not find evidence of a systematic misrepresentation of one sex over another. 
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Race and ethnicity of RCT participants are rarely reported. We found that 25% of RCTs we identified 
had a population that was younger than the surgical population of England by 6.2 years or more, 
with individual RCTs under-representing the national surgical age by up to 33 years. Under-
representation of older people was most consistently seen in RCTs investigating patients undergoing 
hip arthroplasty or surgical management of a fractured neck of femur. The proportion of males and 
females in 41% of the RCTs in our sample was at least 25% higher or lower than in the overall 
surgical population of England. While historically there has been under recruitment of females to 
clinical trials [8], we found no convincing evidence of a consistent sex recruitment bias in our 
sample.  
 
Lack of representation is likely multi-factorial. Individual RCTs are, in theory, a random sample from 
the whole population, so some variation is to be expected, more so with smaller studies. Indeed, if 
such variation was not present, questions might be raised about data integrity [17]. Our study 
reports data from a non-random, purposively sampled range of studies. It is possible, though we 
suggest unlikely, that our selection of studies was biased. We nevertheless found clear evidence that 
study inclusion and exclusion criteria systematically biased against the involvement of older people. 
We did not observe any evidence of criteria that bias for or against males or females.  
 
Older people are often more likely to trigger exclusion criteria regardless of the appropriateness of 
the intervention under investigation. We found evidence of this with 34% of the sample RCTs having 
selection criteria felt to unnecessarily exclude older people and 22% having an upper age limit to 
recruitment. Several other barriers to the recruitment of older people, which could result in a 
selection bias, have been identified [18–20]. Older people may be less likely to consent due to: 
sensory and cognitive limitations; frailty; a reluctance to take on something onerous; or reluctance 
of a family member or caregiver to support an older person in a research project [18]. Investigators 
may be less likely to recruit older people due to apprehension about the impact of enrolling patients 
with multiple comorbidities on dropout rates and adverse events, and logistical concerns regarding 
the inclusion of frailer, older patients [19].  
 
Fewer RCTs involving patients undergoing surgical management of a fractured neck of femur had 
recruitment age limits or other potentially age discriminatory exclusion criteria, and many had a 
lower age limit to recruitment. This likely represents a deliberate effort by researchers to increase 
recruitment of older people. Despite this, the mean or median age of the population in over 75% of 
these RCTs remains below the registry population mean age, highlighting the difficulty in achieving 
age representative recruitment. The extent to which sampling error or selection bias contribute to a 
difference in age between an RCT population and the treated surgical population may not matter in 
terms of the generalisability of any findings. Whether a study is non-representative of the treated 
surgical population by chance, or by design, it still creates a problem with interpretation.  
 
Race or ethnicity of RCT participants was only reported in five RCTs. The relationship between race, 
ethnicity and health outcomes is complex. It has been argued that race and ethnicity serve as proxies 
for a mix of genetic, disease, social, behavioural, or clinical characteristics, that should be considered 
individually rather than under the umbrella of a racial or ethnic group [21]. While it may not be 
appropriate to stratify research by race or ethnicity, awareness of the race and ethnicities of 
research participants is clearly important if researchers are going to consider their potential 
implications and ensure equal opportunities are provided for participation in clinical research.  
 
This analysis has a number of strengths. The purposive sampling strategy resulted in the 
identification of RCTs that were likely to have impacted on clinical practice, and it is therefore of 
importance that their study populations were representative. We sampled 224 RCTs for analysis. 
Randomised controlled trials were only selected if they investigated specific surgical populations for 
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which registry data were available, allowing reliable comparisons to be made between the study and 
registry populations. The availability of annualised English registry data from 1998 to 2017 for all the 
surgical categories, except the surgical management of a fractured neck of femur, allowed these RCT 
populations to be matched by year for comparisons with registry data. 
 
There are several limitations to our analysis. Limited registry data were available for patients 
undergoing surgery for fractured neck of femur. Data on age from the National Hip Fracture 
Database from 2017 and English registry data on sex from 2012 to 2017 were used in the analysis, 
and these RCT populations were, therefore, not matched by year to registry data. Due to a lack of 
openly available international surgical registry data, we were unable to compare RCT population age 
and sex to geographically matched registry populations. Age and sex differences between RCT and 
registry populations will influence the generalisability of RCT findings to the surgical population of 
the country of the registry, but will not necessarily reflect age and sex differences in other countries 
due to geographical variation in the surgical population. We were unable to include RCTs studying 
the effect of a peri-operative intervention on more than one surgical group, as we would have been 
unable to compare the study population age to specific registry data. This resulted in a number of 
potentially influential peri-operative RCTs being excluded from our analysis. 
 
A key issue facing clinical research is an understanding of the impact of ageing, multi-morbidity and 
frailty on outcomes following medical and surgical interventions. This is amplified in the ‘old-old’, 
however this is defined. Neither the RCTs nor the registries provide consistent data on this 
population (e.g. aged > 80 y or identified as being frail) which leaves a clear gap in our understanding 
of this high-risk population. Advances in peri-operative care and a changing national and global 
demographic mean that surgery is being offered to an increasingly diverse population. The evidence 
of non-representative RCT populations in this analysis highlights the importance of endeavouring to 
recruit representative research populations if findings are to be reliably generalised to the overall 
population. Although there is some variation, sex representativeness seems to be adequate. A better 
understanding and awareness of barriers to recruitment of older people when planning clinical trials 
may improve representative recruitment and help ensure research is following patient need. 
Unnecessary age discriminatory exclusion criteria including age limits should clearly be avoided.   
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Legends for figures 
 
Figure 1 – Randomised controlled trial selection flowchart. 
 
Figure 2 – Bubble plots for each surgical category showing the difference between the mean or 
median age of the randomised controlled studies and the mean age of the equivalent populations in 
the English hospital registry according to the middle year of study recruitment. Marker radius is 
proportional to the number of study participants.  
 
Figure 3 – Bubble plots for each surgical category showing the ratio of the proportion of male 
participants in the randomised controlled studies compared with the proportion in the English 
hospital registry according to the middle year of study recruitment. Values less than one represent 
under-representation of males, and greater than one, over-representation. Marker radius is 
proportional to the number of study participants. 
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Figure 3 Click here to access/download;Figure;Figure 3.pdf
S1 - Inclusion/Exclusion Criteria  
 
META-ANALYSIS SELECTION CRITERIA 
-Meta-analysis 
-Not solely studying a paediatric population 
-Published since 2008 
-Review includes but not necessarily limited to the defined surgical population 






Open or laparoscopic 
 
-Elective Arthroplasty 













Nephrectomy – total or partial 
Open or laparoscopic 
 
-Lung resection 
S1 - Selection Criteria Click here to access/download;Supplementary File;S1 -
Selection Critieria.docx
Pneumonectomy/lobectomy/segmentectomy 





Study assessing ERAS pathway: 
Not study of isolated components of ERAS 
 
-GDT 
Study related to perioperative goal directed fluid therapy 
Effect of GDT 
 
-Perioperative blood management 



















STUDY SELECTION CRITERIA 
-RCT 
-Study specific to the defined surgical population 
-Surgical and research categories as defined above 
-English language  
 
S2 – Frequency of procedure stratified by age using 2016-2017 HES data 
 
 














TURBT 31879 26349 19292 12068 5622 1539 
TURP 3379 2546 1615 839 276 50 
Nephrectomy 3601 2480 1466 621 145 17 
Colorectal resection 19784 15021 9894 5540 1978 342 
Primary hip 65760 49824 32668 17165 6515 1554 
Primary Knee 64533 46792 28145 13154 4018 564 
Hip Fracture 34591 33000 30231 25551 17736 8352 
Lung 5735 3896 2086 799 148 9 
Cataract 336787 288660 220909 137896 60599 14933 
S2 - Procedure Frequency Click here to access/download;Supplementary File;S2 - Procedure Frequency.docx
S3 – Search Terms for Surgical Categories and Perioperative Domains 
 
-TURP and TURBT 
MEDLINE (Ovid interface)  
1. Transurethral Resection of Prostate/ 
2. Transurethral resection of prostate.mp. or TURP.mp. 
3. Transurethral resection of bladder tumour.mp. or TURBT.mp. 
4. Transurethral resection.mp. 
5. Urinary Bladder Neoplasms/ or Prostate/ 
6. 4 and 5 
7. 1 or 2 or 3 or 6 
EMBASE (Ovid interface) 
1. Transurethral resection of prostate.mp. or TURP.mp. 
2. Transurethral resection of bladder tumour.mp. or TURBT.mp. 
3. transurethral resection/ 
4. 1 or 2 or 3 
CENTRAL (Wiley Online Library) 
1. MeSH descriptor: [Transurethral Resection of Prostate] explode all trees 
2. Transurethral resection 
3. TURP 
4. TURBT 




MEDLINE (Ovid interface) 
1. NEPHRECTOMY/ or nephrectom*.mp. 
2. renal resection.mp or kidney resection.mp. 
3. 1 or 2 
EMBASE (Ovid interface) 
1. Nephrectomy/ or radical nephrectomy/ or bilateral nephrectomy/ or partial 
nephrectomy/ or nephrectom*.mp. 
2. renal resection.mp or kidney resection.mp. 
3. 1 or 2 
CENTRAL (Wiley Online Library) 
1. MeSH descriptor: [Nephrectomy] explode all trees 
2. Nephrectomy 
3. Renal resection or kidney resection 




S3 - Search Terms Click here to access/download;Supplementary File;S3 -
Search Terms.docx
-COLORECTAL 
MEDLINE (Ovid interface) 
1. Colorectal Surgery/ 
2. ((colorectal or rect* or colon or sigmoid) and (surgery or surgical or procedure or 
resection)).mp. 
3. 1 or 2 
EMBASE (Ovid interface) 
1. colorectal surgery/ 
2. ((colorectal or rect$ or colon or sigmoid) and (surgery or surgical or procedure or 
resection)).mp. 
3. 1 or 2 
CENTRAL (Wiley Online Library) 
1. MeSH descriptor:[Colorectal Surgery] explode all trees 
2. ((colorectal or rect* or colon or sigmoid) and (surgery or surgical or procedure or 
resection)) 
3. #1 or #2 
 
-ELECTIVE LOWER LIMB ARTHROPLASTY 
MEDLINE (Ovid interface) 
1. Arthroplasty, Replacement, Hip/ 
2. (hip* adj5 (replac* or operat* or surg* or arthroplast*)).mp. 
3. Arthroplasty, Replacement, Knee/ 
4. (knee* adj5 (replac* or operat* or surg* or arthroplasty*)).mp. 
5. 1 or 2 or 3 or 4 
EMBASE (Ovid interface) 
1. hip arthroplasty/ 
2. (hip$ adj5 (replac$ or operat$ or surg$ or arthroplast$)).mp. 
3. Knee arthroplasty/ 
4. (knee$ adj5 (replac$ or operat$ or surg$ or arthroplasty$)) 
5. 1 or 2 or 3 or 4 
CENTRAL (Wiley Online Library) 
1. MeSH descriptor: [Arthoplasty, Replacement, Hip] explode all trees 
2. (hip* NEAR (replac* or operat* or surg* or arthroplast*)) 
3. MeSH descriptor: [Arthoplasty, Replacement, Knee] explode all trees 
4. (knee* NEAR (replac* or operat* or surg* or arthroplasty*)) 
5. #1 or #2 or #3 or #4 
 
-#NOF 
MEDLINE (Ovid interface) 
1. Hip Fractures/ 
2. ((hip* or femur* or femoral* or trochant* or pertrochant* or subtrochant* or 
extracapsular*) adj5 fracture*).mp. 
3. 1 or 2 
EMBASE (Ovid interface) 
1. hip fracture/ 
2. ((hip$ or femur$ or femoral$ or trochant$ or pertrochant$ or subtrochant$ or 
extracapsular$) adj5 fracture$).mp. 
3. 1 or 2 
CENTRAL (Wiley Online Library) 
1. MeSH descriptor: [Hip Fractures] explode all trees 
2. ((hip* or femur* or femoral* or trochant* or pertrochant* or subtrochant* or 
extracapsular*) NEAR fracture*) 
3. #1 or #2  
 
-LUNG RESECTION 
MEDLINE (Ovid interface) 
1. PNEUMONECTOMY/ or pneumonectomy.mp. 
2. Thoracic Surgery/ or Thoracotomy/ or thoracic surgery.mp. or thoracotomy.mp. 
3. (pulmonary or lung) and (resection or lobectomy or excision).mp. 
4. 1 or 2 or 3 
EMBASE (Ovid interface) 
1. Lung resection/ 
2. Pneumonectomy.mp.  
3. thoracic surgery.mp or thoracotomy.mp. or thorax surgery/ or thoracotomy/ 
4. ((pulmonary or lung) and (resection or lobectomy or excision).mp. 
5. 1 or 2 or 3 or 4 
CENTRAL (Wiley Online Library) 
1. MeSH descriptor: [Pneumonectomy] explode all trees 
2. MeSH descriptor: [Thoracotomy] explode all trees 
3. MeSH descriptor: [Thoracic Surgery] explode all trees 
4. (pulmonary or lung) and (resection or lobectomy or excision) 
5. #1 or #2 or #3 or #4 
 
-ERAS 
MEDLINE (Ovid interface) 
1. ((enhanced or early) and (rehabilitation* or recovery* or convalesce*)).mp. 
2. Fast track.mp. 
3. ERAS.mp. 
4. 1 or 2 or 3 
EMBASE (Ovid interface) 
1. ((enhanced or early) and (rehabilitation$ or recovery$ or convalesce$)).mp. 
2. Fast track.mp. 
3. ERAS.mp. 
4. 1 or 2 or 3 
CENTRAL (Wiley Online Library) 
1. ((enhanced or early) and (rehabilitation* or recovery* or convalesce*)) 
2. Fast track 
3. ERAS 
4. #1 or #2 or #3 
 
-GDT  
MEDLINE (Ovid interface) 
1. (goal directed or goal orientated or goal target* or goal-directed).mp. 
2. Cardiac Volume/ or (cardiac output or cardiac index or cardiac volume).mp. 
3. Stroke Volume/ or stoke volume.mp. 
4. (oxygen delivery or oxygen consumption).mp. 
5. Fluid Therapy/ or (fluid therapy or fluid loading or fluid administration).mp. 
6. (pulse pressure variation or pleth index variation or systolic pressure 
variation).mp. 
7. (optimisation or optimization).mp. 
8. 1 or 2 or 3 or 4 or 5 or 6 or 7 
EMBASE (Ovid interface) 
1. (goal directed or goal orientated or goal target$ or goal-directed).mp. 
2. heart volume/ 
3. (cardiac output or cardiac index or cardiac volume).mp. 
4. fluid therapy/ or (fluid therapy or fluid loading or fluid administration).mp. 
5. heart stroke volume/ or stoke volume.mp. 
6. (pulse pressure variation or pleth index variation or systolic pressure 
variation).mp. 
7. (oxygen delivery or oxygen consumption).mp. 
8. (optimisation or optimization).mp. 
CENTRAL (Wiley Online Library) 
1. MeSH descriptor: [Fluid Therapy] explode all trees 
2. MeSH descriptor: [Stroke Volume] explode all trees 
3. MeSH descriptor: [Cardiac Output] explode all trees 
4. goal directed or goal orientated or goal target* or goal-directed 
5. cardiac output or cardiac index or cardiac volume 
6. oxygen delivery or oxygen consumption 
7. fluid therapy or fluid loading or fluid administration 
8. pulse pressure variation or pleth index variation or systolic pressure variation 
9. optimisation or optimization 
10. #1 or #2 or #3 or #4 or #5 or #6 or #7 or #8 or #9 
 
-PERI-OPERATIVE BLOOD MANAGEMENT 
MEDLINE (Ovid interface) 
1. IRON/ or iron.mp. 
2. (Ferric compounds/ or FERROUS COMPOUNDS/) or ((ferric or ferrous) adj5 
compound*) 
3. (Blood Transfusion/ or Erythrocyte Transfusion/) 
4. ((transfus* or red cell* or red blood cell* or RBC* or PRBC*) adj5 (trigger* or 
threshold* or target* or restrict* or liberal* or aggressive* or conservative* or 
prophylactic* or limit* or protocol* or policy or policies or practic* or indicat* or 
strateg* or regimen* or criteri* or standard* or management or program*)).mp. 
5. ((h*emoglobin or h*ematocrit or HB or HCT) adj5 (polic* or practic* or protocol* 
or trigger* or threshold* or maintain* or indicator* or strateg* or criteri* or 
standard*)).mp. 
6. (transfu* or posttransfus* or retransfus* or hypertansfus* or h*emotranfus* or 
red cell* or red blood cell* or RBC* or erythrocyte*).mp. 
7. ((allogen*ic adj2 blood) or (blood adj2 exposure) or (unit* adj2 blood) or (blood 
adj3 management) or (blood adj product*) or (blood adj component*) or (donor* 
adj2 blood) or (donat* adj2 blood)).mp.  
8. (blood sparing or cell salvage or cell saver* or (blood adj2 salvag*) or blood 
support or (blood adj2 requir*) or (blood adj2 replac*) or autotransfus*).mp. 
9. Tranexamic Acid/ 
10. (tranexamic acid or amchafibrin or anvitoff or cyklokapron or Sepercil or exacyl or 
lysteda or spotof or t*amcha or tranhexamic acid or transamin or Transcam or 
ugurol).mp. 
11. Perioperative Period/  
12. Perioperative Care/ 
13. (Preoperative or perioperative or postoperative).mp. 
14. ((prior or before or post or after) adj3 (surg* or operat*)).mp. 
15. 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10 
16. 11 or 12 or 13 or 14 
17. 15 and 16 
 
EMBASE (Ovid interface) 
1. Iron/ or iron.mp. 
2. ((ferrous or ferric) adj5 compound$).mp. 
3. (Blood Transfusion/ or Erythrocyte Transfusion/) 
4. ((transfus$ or red cell$ or red blood cell$ or RBC$ or PRBC$) adj5 (trigger$ or 
threshold$ or target$ or restrict$ or liberal$ or aggressive$ or conservative$ or 
prophylactic$ or limit$ or protocol$ or policy or policies or practic$ or indicat$ or 
strateg$ or regimen$ or criteri$ or standard$ or management or program$)).mp.  
5. ((h?emoglobin or h?ematocrit or HB or HCT) adj5 (polic$ or practic$ or protocol$ 
or trigger$ or threshold$ or maintain$ or indicator$ or strateg$ or criteri$ or 
standard$)).mp. 
6. (transfu$ or posttransfus$ or retransfus$ or hypertansfus$ or h?emotranfus$ or 
red cell$ or red blood cell$ or RBC$ or erythrocyte$).mp.  
7. ((allogen?ic adj2 blood) or (blood adj2 exposure) or (unit$ adj2 blood) or (blood 
adj3 management) or (blood adj product$) or (blood adj component$) or (donor$ 
adj2 blood) or (donat$ adj2 blood)).mp. 
8. (blood sparing or cell salvage or cell saver$ or (blood adj2 salvag$) or blood 
support or (blood adj2 requir$) or (blood adj2 replac$) or autotransfus$).mp.  
9. tranexamic acid/ 
10. (tranexamic acid or amchafibrin or anvitoff or cyklokapron or Sepercil or exacyl or 
lysteda or spotof or t?amcha or tranhexamic acid or transamin or Transcam or 
ugurol).mp. 
11. preoperative care/ or preoperative treatment/ or preoperative period/ or 
perioperative period/ 
12. (Preoperative or perioperative or postoperative).mp. 
13. ((prior or before or post or after) adj3 (surg$ or operat$)).mp.  
14. 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 
15. 9 or 10 or 11 or 12 or 13 
16. 14 and 15 
 
CENTRAL (Wiley Online Library) 
1. MeSH descriptor: [Iron] in all MeSH products 
2. MeSh descriptor: [Ferric Compounds] explode all trees 
3. ((ferric or ferrous) near compound*) 
4. MeSH descriptor [Blood Transfusion] explode all trees  
5. MeSH descriptor [Erythrocyte Transfusion] explode all trees 
6. ((transfus* or red cell* or red blood cell* or RBC* or PRBC*) near (trigger* or 
threshold* or target* or restrict* or liberal* or aggressive* or conservative* or 
prophylactic* or limit* or protocol* or policy or policies or practic* or indicat* or 
strateg* or regimen* or criteri* or standard* or management or program*)) 
7. ((h*emoglobin or h*ematocrit or HB or HCT) near (polic* or practic* or protocol* 
or trigger* or threshold* or maintain* or indicator* or strateg* or criteri* or 
standard*)) 
8. (transfu* or posttransfus* or retransfus* or hypertansfus* or h*emotranfus* or 
red cell* or red blood cell* or RBC* or erythrocyte*) 
9. ((allogen*ic near blood) or (blood near exposure) or (unit* near blood) or (blood 
near management) or (blood near product*) or (blood near component*) or 
(donor* near blood) or (donat* near blood)) 
10. (blood sparing or cell salvage or cell saver* or (blood near salvag*) or blood 
support or (blood near requir*) or (blood near replac*) or autotransfus*) 
11. MeSH descriptor: [Tranexamic Acid] explode all trees 
12. (tranexamic acid or amchafibrin or anvitoff or cyklokapron or Sepercil or exacyl or 
lysteda or spotof or t*amcha or tranhexamic acid or transamin or Transcam or 
ugurol) 
13. MeSH descriptor: [Preopeative Care] explode all trees 
14. MeSH descriptor: [Preoperative Period] explode all trees 
15. MeSH descriptor: [Perioperative Period] explode all trees 
16. (Preoperative or perioperative or postoperative) 
17. ((prior or before or post or after) near (surg* or operat*)) 
18. #1 or #2 or #3 or #4 or # or #5 or #6 or #7 or #8 or #9 or #10 or #11 or #12 
19. #13 or #14 or #15 or #16 or #17 
20. #18 and #19 
 
-PAIN 
MEDLINE (Ovid interface) 
1. postoperative pain/ 
2. (pain* and (postoperative or post operative or surg*)).mp. 
3. 1 or 2 
EMBASE (Ovid interface) 
1. postoperative pain/ 
2. (pain$ and (postoperative or post operative or surg$)).mp. 
3. 1 or 2 
CENTRAL (Wiley Online Library) 
1. MeSH descriptor: [Pain, Postoperative] explode all trees 
2. (pain* and (postoperative or post operative or surg*)).mp. 
3. 1 or 2 
 
-PRE-OP OPTIMISATION 
MEDLINE (Ovid interface) 
1. Exercise Test/ or (exercise test or exercise capacity or cardiopulmonary exercise 
or cardiopulmonary reserve).mp. 
2. Anaerobic Threshold/ or (anaerobic threshold, aerobic capacity or aerobic 
fitness).mp. 
3. Oxygen Consumption/ or (oxygen consumption or peak oxygen).mp. 
4. (CPET or CPEX or VO2).mp. 
5. PREOPERATIVE PERIOD/ or PREOPERATIVE CARE/ 
6. (preoperative or pre-operative or pre-surgery).mp. 
7. 1 or 2 or 3 or 4 or 5 
8. 5 or 6 
9. 7 and 8 
10. (prehab* or (preoperative and (rehabilitation or exercise or training or 
physiotherapy or physical therapy or exercise training))).mp. 
11. EXERCISE/ and 8 
12. 9 or 10 or 11 
EMBASE (Ovid interface) 
1. exercise test/ or (exercise test or exercise capacity or cardiopulmonary exercise 
or cardiopulmonary reserve).mp. 
2. (anaerobic threshold, aerobic capacity or aerobic fitness).mp. 
3. oxygen consumption/ or (oxygen consumption or peak oxygen).mp. 
4. (CPET or CPEX or VO2).mp. 
5. Preoperative care/ or preoperative period/ 
6. (preoperative or pre-operative or pre-surgery).mp. 
7. 1 or 2 or 3 or 4 or 5 
8. 5 or 6 
9. 7 or 8 
10. (prehab$ or (preoperative and (rehabilitation or exercise or training or 
physiotherapy or physical therapy or exercise training))).mp. 
11. exercise/ and 8 
12. 9 or 10 or 11 
CENTRAL (Wiley Online Library) 
1. MeSH descriptor: [Exercise Test] explode all trees 
2. MeSH descriptor: [Anaerobic Threshold] explode all trees 
3. MeSH descriptor: [Oxygen Consumption] explode all trees 
4. exercise test or exercise capacity or cardiopulmonary exercise or cardiopulmonary 
reserve 
5. anaerobic threshold, aerobic capacity or aerobic fitness 
6. oxygen consumption or peak oxygen 
7. CPET or CPEX or VO2 
8. MeSH descriptor: [Preoperative Care] explode all trees 
9. MeSH descriptor: [Preoperative Period] explode all trees 
10. Preoperative or pre-operatice or pre-surgery 
11. #1 or #2 or #3 or #4 or #5 or #6 or #7 
12. #8 or #9 or #10 
13. #11 and #12 
14. prehab* or (preoperative and (rehabilitation or exercise or training or 
physiotherapy or physical therapy or exercise training)) 
15. MeSH descriptor: [Exercise] explode all trees 
16. #15 and #12 
17. #13 or #14 or #16 
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S6 – Analyses using HES, GBE, AIHW and NHFD data 
 































Procedure Registry Min q25 Median q75 Max 
All HES(NHFD) -34.6809 -6.1901 -2.35629 0.981484 14.545 
 HES -33.0917 -6.17563 -1.90461 1.096123 14.545 
 GBE -31.7238 -7.55545 -3.07469 0.048821 17.61159 
 AIHW -28.5167 -4.70708 -0.80977 2.398872 18.27774 
Colorectal HES -28.2257 -4.26041 0.304695 3.023033 9.832649 
 GBE -31.7238 -8.40224 -3.31587 0.868568 7.269524 
 AIHW -28.5167 -4.46523 0.364212 2.826591 10.59104 
Hip HES -18.6405 -9.42756 -6.1901 -2.86228 4.609863 
 GBE -20.9987 -11.9552 -8.33936 -5.18903 3.198608 
 AIHW -18.7561 -10.0581 -6.08201 -3.00547 4.698059 
Knee HES -8.82103 -3.24651 -1.68695 0.288216 6.094757 
 GBE -8.46256 -3.20728 -1.71823 0.429756 6.343826 
 AIHW -7.33189 -1.73556 -0.39561 1.741684 7.548225 
NOF HES -33.0917 -7.98681 -1.85581 0.451012 4.465836 
 NHFD -34.6809 -9.576 -3.44501 -1.13818 2.87664 
Lung HES -23.5458 -6.57 -0.05827 3 14.545 
 GBE -20.5185 -5.33481 2.617842 5.738934 17.61159 
 AIHW -19.4637 -3.85254 4.073856 6.741352 18.27774 
S6 - Individual Registry Analyses Click here to access/download;Supplementary File;S6 -
Individual registry analyses.docx
Summary measures of the ratio of the proportion of male participants in the 
study compared to the proportion in the registry for each registry 
Procedure Registry Min q25 Median q75 Max 
All HES 0.173505 0.826214 1.067265 1.243704 2.666358 
 GBE 0.254528 0.871969 1.094538 1.232728 2.81669 
  AIHW 0.166955 0.78645 1.046821 1.240336 2.483572 
Colorectal HES 0.557685 1.020133 1.119786 1.224439 1.411036 
 GBE 0.54967 1.023178 1.111122 1.220935 1.422793 
  AIHW 0.584254 1.064218 1.199177 1.300191 1.511076 
Hip HES 0.474404 1.019272 1.198132 1.393673 2.652365 
 GBE 0.48771 1.073242 1.240116 1.434457 2.81669 
  AIHW 0.422475 0.911814 1.083268 1.252788 2.400206 
Knee HES 0.220187 0.617954 0.772217 1.034822 1.527217 
 GBE 0.254528 0.71221 0.940175 1.232892 1.942955 
  AIHW 0.213959 0.591925 0.769482 1.016522 1.516606 
NOF HES 0.173505 0.7422 0.913311 1.210451 2.666358 
Lung HES 0.569181 0.91801 1.090541 1.352014 1.712668 
 GBE 0.528709 0.758334 0.918951 1.147904 1.42055 
 AIHW 0.566154 0.839987 1.023957 1.279466 1.586719 
